World Health Organization. Cardiovascular diseases (CVDs) [Internet]. Geneva: World Health Organization; 2017 [cited 2019 July 14].
Statistics Korea. Causes of death statistics 2017 [Internet]. Daejeon: Statistics Korea; 2018 [cited 2019 July 14].
Gallagher LG, Davis LB, Ray RM, Psaty BM, Gao DL, Checkoway H, et al. Reproductive history and mortality from cardiovascular disease among women textile workers in Shanghai, China. Int J Epidemiol 2011; 40: 1510-8.
Merritt MA, Riboli E, Murphy N, Kadi M, Tjønneland A, Olsen A, et al. Reproductive factors and risk of mortality in the European Prospective Investigation into Cancer and Nutrition; a cohort study. BMC Med 2015; 13: 252.
Parikh NI, Jeppson RP, Berger JS, Eaton CB, Kroenke CH, LeBlanc ES, et al. Reproductive risk factors and coronary heart disease in the Women’s Health Initiative Observational Study. Circulation 2016; 133: 2149-58.
Canoy D, Beral V, Balkwill A, Wright FL, Kroll ME, Reeves GK, et al. Age at menarche and risks of coronary heart and other vascular diseases in a large UK cohort. Circulation 2015; 131: 237-44.
Dekker JM, Schouten EG. Number of pregnancies and risk of cardiovascular disease. N Engl J Med 1993; 329: 1893-4; author reply 1894-5. Lawlor DA, Emberson JR, Ebrahim S, Whincup PH, Wannamethee SG, Walker M, et al. Is the association between parity and coronary heart disease due to biological effects of pregnancy or adverse lifestyle risk factors associated with child-rearing? Findings from the British Women’s Heart and Health Study and the British Regional Heart Study. Circulation 2003; 107:1260-4.
Wang N, Qin MZ, Cui J. [Lipid profile comparison between pre- and postmenopausal women]. Zhonghua Xin Xue Guan Bing Za Zhi 2016; 44: 799-804. Chinese.
Mesalić L, Tupković E, Kendić S, Balić D. Correlation between hormonal and lipid status in women in menopause. Bosn J Basic Med Sci 2008; 8: 188-92.
Au Yeung SL, Jiang C, Cheng KK, Xu L, Zhang W, Lam TH, et al. Age at menarche and cardiovascular risk factors using Mendelian randomization in the Guangzhou Biobank Cohort Study. Prev Med 2017; 101: 142-8.
Lakshman R, Forouhi NG, Sharp SJ, Luben R, Bingham SA, Khaw KT, et al. Early age at menarche associated with cardiovascular disease and mortality. J Clin Endocrinol Metab 2009; 94: 4953-60.
Murakami K, Metoki H, Satoh M, Asayama K, Hosaka M, Matsuda A, et al. Menstrual factors and stroke incidence in Japanese postmenopausal women:the Ohasama Study. Neuroepidemiology 2016; 47: 109-16.
Hsieh YC, Hwang LC, Hsieh FI, Lien LM, Lin HJ, Hu CJ, et al. Early menarche and ischemic stroke risk among postmenopausal women. Int J Gerontol 2010; 4: 16-22.
Bralić I, Tahirović H, Matanić D, Vrdoljak O, Stojanović-Spehar S, Kovacić V, et al. Association of early menarche age and overweight/obesity. J Pediatr Endocrinol Metab 2012; 25: 57-62.
Koellhoffer EC, McCullough LD. The effects of estrogen in ischemic stroke. Transl Stroke Res 2013; 4: 390-401.
Chang HS, Odongua N, Ohrr H, Sull JW, Nam CM. Reproductive risk factors for cardiovascular disease mortality among postmenopausal women in Korea: the Kangwha Cohort Study, 1985-2005. Menopause 2011; 18: 1205-12.
Sim JH, Chung D, Lim JS, Lee MY, Chung CH, Shin JY, et al. Maternal age at first delivery is associated with the risk of metabolic syndrome in postmenopausal women: from 2008-2010 Korean National Health and Nutrition Examination Survey. PLoS One 2015; 10: e0127860.
Nguyen B, Jin K, Ding D. Breastfeeding and maternal cardiovascular risk factors and outcomes: a systematic review. PLoS One 2017; 12: e0187923.
Kirkegaard H, Bliddal M, Støvring H, Rasmussen KM, Gunderson EP, Køber L, et al. Breastfeeding and later maternal risk of hypertension and cardiovascular disease - the role of overall and abdominal obesity. Prev Med 2018; 114: 140-8.
Zhang X, Shu XO, Gao YT, Yang G, Li H, Zheng W. Pregnancy, childrearing, and risk of stroke in Chinese women. Stroke 2009; 40: 2680-4.
Zhang Y, Shen L, Wu J, Xu G, Song L, Yang S, et al. Parity and risk of stroke among Chinese women: cross-sectional evidence from the DongfengTongji Cohort Study. Sci Rep 2015; 5: 16992.
Jacobsen BK, Knutsen SF, Oda K, Fraser GE. Parity and total, ischemic heart disease and stroke mortality. The Adventist Health Study, 1976-1988. Eur J Epidemiol 2011; 26: 711-8.
Hannaford PC, Croft PR, Kay CR. Oral contraception and stroke. Evidence from the Royal College of General Practitioners’ Oral Contraception Study. Stroke 1994; 25: 935-42.
Gerstman BB, Piper JM, Tomita DK, Ferguson WJ, Stadel BV, Lundin FE. Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease. Am J Epidemiol 1991; 133: 32-7.
Zeitoun K, Carr BR. Is there an increased risk of stroke associated with oral contraceptives? Drug Saf 1999; 20: 467-73.
Ciccone A, Melis M. Ischemic stroke risk in oral contraceptive users. Stroke 2003; 34: e231; author reply e231.
Weill A, Dalichampt M, Raguideau F, Ricordeau P, Blotière PO, Rudant J, et al. Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women:cohort study. BMJ 2016; 353: i2002.